Tela Bio Inc Reports Results For The Quarter Ended March 31: Earnings Summary

TELA Bio

08/05/2025 22:52

TELA Bio Inc TELA.OQ reported a quarterly adjusted loss of 25 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of -23 cents.  The mean expectation of five analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -27 cents to -12 cents per share.

Revenue rose 11.5% to $18.52 million from a year ago; analysts expected $17.36 million.

TELA Bio Inc's reported EPS for the quarter was a loss of 25 cents​.

The company reported a quarterly loss of $11.26 million.

TELA Bio Inc shares had fallen by 22.1% this quarter and lost 68.5% so far this year.

FORECAST CHANGES

The mean earnings estimate of analysts had risen by about 5.2% in the last three months.​

In the last 30 days, there have been no negative revisions of earnings estimates

RECOMMENDATIONS

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for TELA Bio Inc is $7.00

This summary was machine generated from LSEG data May 8 at 09:52 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING
ESTIMATE
ACTUAL
BEAT, MET, MISSED
Mar. 31 2025
-0.20
-0.25
Missed
Dec. 31 2024
-0.22
-0.23
Missed
Sep. 30 2024
-0.40
-0.42
Missed
Jun. 30 2024
-0.47
-0.51
Missed